RAYMOND JAMES & ASSOCIATES - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q3 2022$2,122,000
-70.7%
41,068
-88.5%
0.00%
-71.4%
Q2 2022$7,250,000
-8.6%
357,020
-13.3%
0.01%
+16.7%
Q1 2022$7,934,000
-21.6%
411,633
+48.2%
0.01%
-25.0%
Q4 2021$10,116,000
+66.5%
277,838
-21.8%
0.01%
+60.0%
Q3 2021$6,074,000
+29.5%
355,190
+1.4%
0.01%
+25.0%
Q2 2021$4,690,000
-65.8%
350,286
+30.9%
0.00%
-71.4%
Q1 2021$13,712,000
-3.0%
267,607
+17.2%
0.01%
-12.5%
Q4 2020$14,143,000
+215.2%
228,403
+179.0%
0.02%
+166.7%
Q3 2020$4,487,000
+22.5%
81,879
+28.7%
0.01%
+20.0%
Q2 2020$3,662,000
+59.9%
63,637
+11.6%
0.01%
+25.0%
Q1 2020$2,290,000
+86.6%
57,003
+83.8%
0.00%
+100.0%
Q4 2019$1,227,000
+815.7%
31,014
+56.9%
0.00%
Q3 2019$134,000
-2.9%
19,767
+33.3%
0.00%
Q2 2019$138,000
-28.5%
14,824
+6.8%
0.00%
Q1 2019$193,000
+45.1%
13,874
+14.0%
0.00%
Q4 2018$133,00012,1740.00%
Other shareholders
CHEMOCENTRYX INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tri Locum Partners LP 545,532$13,518,0005.54%
Integral Health Asset Management, LLC 574,029$14,224,0002.93%
HealthCor Management, L.P. 1,097,370$27,193,0002.73%
Logos Global Management LP 600,000$14,868,0002.73%
Cormorant Asset Management, LP 1,425,000$35,312,0002.67%
Altium Capital Management LP 160,000$3,965,0001.59%
Cahill Wealth Management, LLC 68,358$1,693,0001.43%
Hood River Capital Management LLC 1,336,776$33,125,0001.32%
Sofinnova Investments, Inc. 636,659$15,776,0001.31%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 3,000$121,100,0001.26%
View complete list of CHEMOCENTRYX INC shareholders